All In MedTech

Device Trial Radar · NCT02383160

Scaphoid Non-union and Low-intensity Pulsed Ultrasound Trial

A Randomized Controlled Trial Comparing Low-Intensity, Pulsed Ultrasound to Placebo in the Treatment of Operatively Managed Scaphoid Non-Unions

Last checked: Nov 20, 2026Latest source record: May 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 154 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

154

Planned (sponsor's estimate)

Start

Sep 2014

Primary completion

Dec 31, 2022

Study completion Dec 31, 2023

Sponsor

Lead sponsor
University of CalgaryAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Workers' Compensation Board, Alberta; Calgary Orthopaedic Research and Education Fund; Bioventus LLC
First posted
Mar 9, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, double-blind, multicentered, randomized controlled trial to determine the effectiveness of low-intensity pulsed ultrasound in decreasing the time to union of scaphoid non-unions after operative fixation as measured by serial CT scanning. Multiple centers across Canada will be involved in the study. Blinding will include patients, surgeons, research assistants, as well as all data handlers and analysts until trial completion or mid-term analysis.

Conditions

  • Nonunion of Fracture of Scaphoid Bone
  • Fractures, Ununited

Interventions

  • Bioventus Exogen 4000: Low-intensity pulsed ultrasoundDevice

    Active low-intensity pulsed ultrasound

  • Sham deviceDevice

    Placebo device with no active therapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to radiographic union as evidenced on serial CT scansTime frame: up to 52 weeks

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • South Health Campus

    Calgary, Alberta, Canada

  • Peter Lougheed Centre

    Calgary, Alberta, Canada

  • St. Paul's Hospital

    Vancouver, British Columbia, Canada

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.